However, more studies are needed to confirm that TRAF2 may accelerate the progression of HBV-associated liver fibrosis by encouraging the release of the inflammatory factors TNFα and IL8 through the TAK1/P38 or TAK1/NF-kB signaling pathways. Here, NFKB1 is linked to Hepatic fibrosis.